title: Vilanterol trifenatate/fluticasone furoate, lomitapide mesylate, and mipomersen sodium.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Afsheen
authors.initials: A
authors.lastname: Ahmad
mesh_terms: D000730:Androstadienes / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D009841:Oligonucleotides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000730:Androstadienes; D000924:Anticholesteremic Agents; C473731:BMS201038; D001562:Benzimidazoles; D001592:Benzyl Alcohols; D001993:Bronchodilator Agents; D002722:Chlorobenzenes; D004338:Drug Combinations; D009841:Oligonucleotides; C550468:vilanterol; C524142:mipomersen; C523187:fluticasone furoate